Journal article
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation
Abstract
Importance: Congestive heart failure (CHF) is commonly associated with nonvalvular atrial fibrillation (AF), and their combination may affect treatment strategies and outcomes.
Objective: To assess the treatment strategies and 1-year clinical outcomes of antithrombotic and CHF therapies for patients with newly diagnosed AF with concomitant CHF stratified by etiology (ischemic cardiomyopathy [ICM] vs nonischemic cardiomyopathy [NICM]).
Authors
Corbalan R; Bassand J-P; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S
Journal
JAMA Cardiology, Vol. 4, No. 6, pp. 526–548
Publisher
American Medical Association (AMA)
Publication Date
June 1, 2019
DOI
10.1001/jamacardio.2018.4729
ISSN
2380-6583
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Adrenergic beta-AntagonistsAgedAged, 80 and overAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAnticoagulantsAtrial FibrillationCardiomyopathiesCardiotonic AgentsCardiovascular DiseasesCohort StudiesDigoxinFemaleGuideline AdherenceHeart FailureHemorrhageHumansMaleMiddle AgedMineralocorticoid Receptor AntagonistsMortalityMyocardial IschemiaPlatelet Aggregation InhibitorsPractice Guidelines as TopicProportional Hazards ModelsRegistriesSodium Potassium Chloride Symporter InhibitorsStrokeStroke Volume